Paul O’Brien's most recent trade in Tvardi Therapeutics Inc. was a trade of 7,213 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc. | Stephen Paul O’Brien | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 7,213 | 7,213 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc. | Stephen Paul O’Brien | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 11,399 | 11,399 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc. | Stephen Paul O’Brien | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 3,352 | 3,352 | - | - | Employee Stock Option (right to buy) | |
| MariaDB Plc - Ordinary Sha... | Paul O’Brien | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.55 per share. | 25 Jul 2024 | 975,000 | 0 | - | 0.6 | 536,250 | Ordinary Shares |
| MariaDB Plc - Ordinary Sha... | Paul O’Brien | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.55 per share. | 25 Jul 2024 | 325,000 | 0 | - | 0.6 | 178,750 | Ordinary Shares |
| MariaDB Plc - Ordinary Sha... | Paul O’Brien | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2023 | 1,300,000 | 1,300,000 | - | 0 | Ordinary Shares |